| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $8.0M | — | +41.2% |
| SG&A Expense | $2.5M | — | +0.3% |
| Operating Income | -$10.5M | — | -28.7% |
| Pre-tax Income | -$10.0M | — | -30.3% |
| Income Tax | $7K | — | +16.7% |
| Net Income | -$10.0M | — | -30.3% |
| EPS (Basic) | -$0.19 | — | -5.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.9M | -68.9% | +88.0% |
| Short-term Investments | $46.5M | +5.0% | +37.7% |
| Accounts Receivable | $301K | +16.7% | +19.0% |
| Current Assets | $52.4M | -13.6% | +39.9% |
| Total Assets | $53.1M | -13.5% | +36.7% |
| Current Liabilities | $5.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.1M | — | -27.0% |
| Capital Expenditures | $8K | — | -33.3% |
| Investing Cash Flow | -$2.1M | — | -131.9% |
| Financing Cash Flow | $417K | — | +358.2% |
| Free Cash Flow | -$9.1M | — | -26.9% |
| +23.2% |
| Stockholders' Equity | $47.2M | -15.8% | +39.1% |